Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 2 |
2022 | 2 |
2023 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
Beyond PACIFIC: Real-World Outcomes of Adjuvant Durvalumab According to Treatment Received and PD-L1 Expression.
Curr Oncol. 2023 Aug 8;30(8):7499-7507. doi: 10.3390/curroncol30080543.
Curr Oncol. 2023.
PMID: 37623024
Free PMC article.
Upfront Next Generation Sequencing in Non-Small Cell Lung Cancer.
Kuang S, Fung AS, Perdrizet KA, Chen K, Li JJN, Le LW, Cabanero M, Karsaneh OAA, Tsao MS, Morganstein J, Ranich L, Smith AC, Wei C, Cheung C, Shepherd FA, Liu G, Bradbury P, Pal P, Schwock J, Sacher AG, Law JH, Stockley TL, Leighl NB.
Kuang S, et al.
Curr Oncol. 2022 Jun 22;29(7):4428-4437. doi: 10.3390/curroncol29070352.
Curr Oncol. 2022.
PMID: 35877212
Free PMC article.
Item in Clipboard
Comparison of 2-Weekly Versus 4-Weekly Durvalumab Consolidation for Locally Advanced NSCLC Treated With Chemoradiotherapy: A Brief Report.
Denault MH, Kuang S, Shokoohi A, Leung B, Liu M, Berthelet E, Laskin J, Sun S, Zhang T, Melosky B, Ho C.
Denault MH, et al. Among authors: kuang s.
JTO Clin Res Rep. 2022 Mar 30;3(5):100316. doi: 10.1016/j.jtocrr.2022.100316. eCollection 2022 May.
JTO Clin Res Rep. 2022.
PMID: 35498385
Free PMC article.
Item in Clipboard
Concurrent Chemoradiation With or Without Durvalumab in Elderly Patients With Unresectable Stage III NSCLC: Safety and Efficacy.
Lau SCM, Ryan M, Weiss J, Fares AF, Garcia M, Schmid S, Kuang S, Kelly D, Tsao MS, Bradbury PA, Cho BCJ, Sun A, Raman S, Hope A, Giuliani M, Lok BH, Bezjak A, Liu G, Leighl NB, Shepherd FA, Sacher AG.
Lau SCM, et al. Among authors: kuang s.
JTO Clin Res Rep. 2021 Nov 2;2(12):100251. doi: 10.1016/j.jtocrr.2021.100251. eCollection 2021 Dec.
JTO Clin Res Rep. 2021.
PMID: 34917991
Free PMC article.
Item in Clipboard
Lorlatinib in ALK-Rearranged Lung Cancer.
Kuang S, Leighl NB.
Kuang S, et al.
Cancer Cell. 2021 Jan 11;39(1):25-27. doi: 10.1016/j.ccell.2020.12.017.
Cancer Cell. 2021.
PMID: 33434512
Free article.
Item in Clipboard
Cite
Cite